Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...
Zacks Investment Research on MSN
Elekta wins FDA nod for Evo CT-Linac, boosting US radiation oncology
Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system ...
Aug. 19—LENOIR — McCreary Cancer Center, a service of UNC Hospitals, is expanding in Lenoir. The expansion will add a brand new Elekta Infinity linear accelerator to the city. The Elekta unit delivers ...
STOCKHOLM, March 8, 2019 /PRNewswire/ -- With the number of new cancer cases globally expected to rise by about 70 percent over the next two decades1-2, access to radiotherapy – a key treatment ...
Elekta a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders, announced that The University of Texas MD Anderson Cancer Center has ...
STOCKHOLM, Oct. 17, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has been awarded the Institute of Physics (IOP) Business ...
GUANGZHOU, China, Jan. 15, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) and HEDY Group of Guangzhou, China, recently signed an agreement for 10 linear accelerators (linacs) as well as Monaco® treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results